Female hair loss at the temples is a distressing yet frequently overlooked condition that affects women of all ages. Whether caused by hormonal shifts, traction from tight hairstyles, or autoimmune conditions such as frontal fibrosing alopecia, temple thinning can progress silently before becoming noticeable. Understanding the underlying cause is essential, as treatment options and outcomes vary considerably. This guide covers the most common causes of temple hair loss in women, when to seek medical advice, what tests and treatments are available on the NHS and privately, and practical steps to support regrowth and scalp health.

Why Women Experience Hair Loss at the Temples

Temple hair loss in women occurs because follicles in this area are sensitive to hormonal changes, mechanical tension, and inflammation, leading to gradual miniaturisation of the hair shaft over time.

Not sure if this is normal? Chat with one of our pharmacists →

Female hair loss at the temples is more common than many people realise, yet it remains underdiagnosed and can be emotionally distressing. Unlike male-pattern baldness, which tends to follow a well-recognised receding hairline, temple hair loss in women can be subtle at first — presenting as gradual thinning, reduced density, or a widening of the hairline at the sides of the forehead.

The temples are a particularly vulnerable area because the hair follicles here are sensitive to hormonal fluctuations, mechanical tension, and inflammatory processes. In women, these follicles can miniaturise over time — a process where the anagen (growth) phase shortens, producing progressively finer, vellus-like hairs. In non-scarring conditions, follicles retain the potential to respond to treatment; in scarring alopecias, follicle damage may become permanent if the condition is not addressed promptly.

It is worth noting that many cases of temple hair loss have benign, treatable causes — such as androgenetic alopecia or traction alopecia — though assessment can also identify underlying hormonal, nutritional, or autoimmune conditions that benefit from treatment. Postpartum telogen effluvium is another common and usually self-limiting cause: significant hair shedding, which can accentuate thinning at the temples, often occurs two to four months after childbirth as hormone levels readjust. Recognising the pattern and seeking timely advice can make a meaningful difference to outcomes, particularly when identified early.

Common Causes of Temple Hair Loss in Women

The most common causes include frontal fibrosing alopecia, traction alopecia, androgenetic alopecia, telogen effluvium, thyroid dysfunction, and nutritional deficiencies such as low ferritin.

There are several well-established causes of female hair loss at the temples, and in many cases more than one factor may be contributing simultaneously.

Frontal Fibrosing Alopecia (FFA) is an important cause of temple and frontal hairline recession, particularly in post-menopausal women. It is a form of scarring alopecia with an autoimmune component, and early intervention is important to slow progression. A helpful supporting sign is loss of the eyebrows, and perifollicular redness or scaling at the frontal hairline may also be present.

Traction alopecia is a significant and common cause, resulting from repeated mechanical tension on the hair follicles. Tight hairstyles such as high ponytails, braids, extensions, or weaves place sustained stress on the temples, gradually damaging follicles over time. When identified early and the source of tension removed, recovery is often possible.

Androgenetic alopecia (female-pattern hair loss) can also affect the temples, though it more classically causes diffuse thinning over the crown. Hormonal changes associated with the menopause, polycystic ovary syndrome (PCOS), or stopping the combined oral contraceptive pill may trigger or worsen this pattern.

Other contributing causes include:

• Telogen effluvium — diffuse shedding triggered by physical or emotional stress, illness, surgery, rapid weight loss, or the postpartum period

• Medication-induced hair loss — certain medicines, including retinoids, anticoagulants, and some thyroid drugs, can cause or worsen hair shedding; review your current medicines with your GP if this is a concern

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism can cause hair thinning

• Nutritional deficiencies — particularly iron and ferritin; vitamin D and zinc deficiencies may also contribute in some individuals, though evidence is less robust

• Alopecia areata — an autoimmune condition that can cause patchy loss, including at the temples

Identifying the underlying cause is essential before any treatment is considered.

When to See a GP or Dermatologist

You should see a GP if temple thinning is progressive, accompanied by scalp redness or scaling, eyebrow loss, or systemic symptoms such as fatigue or irregular periods, as early assessment improves outcomes.

Many women delay seeking help for temple hair loss, often attributing it to normal ageing or stress. However, early assessment is strongly advisable, particularly if the hair loss is progressive, associated with other symptoms, or causing significant distress.

You should contact your GP if you notice:

• Visible thinning or recession at the temples that has worsened over several months

• Hair loss accompanied by scalp itching, burning, redness, or scaling — particularly perifollicular redness or scale at the frontal hairline, which may suggest scarring alopecia

• Loss of the eyebrows, which can be an early feature of frontal fibrosing alopecia

• Associated symptoms such as fatigue, weight changes, irregular periods, or acne — which may suggest a hormonal or thyroid condition

• Patchy hair loss elsewhere on the scalp or body

• A family history of autoimmune conditions or significant hair loss

GPs can carry out initial blood tests and provide referrals to NHS dermatology services where appropriate. If scarring alopecia such as frontal fibrosing alopecia is suspected, prompt referral to a consultant dermatologist is particularly important, as follicle damage in these conditions can be permanent if left untreated.

Private dermatology consultations are also available for those who wish to access specialist assessment more quickly. A registered trichologist (a specialist in hair and scalp health) can offer assessment and advice on non-scarring conditions; however, trichologists are not medically regulated, and suspected scarring alopecia should be assessed by a consultant dermatologist. The Institute of Trichologists and the British Association of Dermatologists both maintain registers of qualified practitioners in the UK.

Diagnosis and Tests Used in the UK

Diagnosis involves clinical history, dermoscopy, and targeted blood tests including ferritin, thyroid function, and full blood count; a scalp biopsy may be needed if scarring alopecia is suspected.

Diagnosing the cause of female hair loss at the temples involves a combination of clinical assessment, scalp examination, and targeted investigations. There is no single definitive test, and a thorough history — including medication use, dietary habits, recent illnesses, postpartum status, and hairstyling practices — is an essential part of the diagnostic process.

Investigations are guided by the clinical picture rather than requested routinely for all patients. Tests commonly considered include:

• Full blood count (FBC) — to check for anaemia

• Serum ferritin and iron studies — low ferritin is a well-recognised contributor to hair shedding and is routinely checked

• Thyroid function tests (TFTs) — to exclude hypothyroidism or hyperthyroidism

• Hormonal profile — including testosterone, DHEAS, and sex hormone-binding globulin (SHBG), but only where there are clinical features suggesting hyperandrogenism or PCOS (such as irregular periods, acne, or hirsutism)

• Vitamin D, zinc, vitamin B12, folate, or coeliac serology — considered selectively based on symptoms, dietary history, or examination findings, rather than as a routine panel

• Inflammatory markers (ESR or CRP) — if autoimmune disease is suspected

Dermatologists may also use dermoscopy (trichoscopy) — a non-invasive technique using a handheld magnifying device — to examine the scalp and hair follicles in detail. This can help distinguish between scarring and non-scarring alopecias and identify characteristic patterns associated with specific diagnoses.

In some cases, a scalp biopsy may be recommended, particularly when frontal fibrosing alopecia or another scarring alopecia is suspected. This involves removing a small sample of scalp tissue under local anaesthetic for histological analysis. Whilst this may sound daunting, it is a straightforward outpatient procedure that can provide definitive diagnostic information and guide treatment decisions.

Treatment Options Available on the NHS and Privately

Treatment depends on the underlying cause; options include topical minoxidil for non-scarring alopecia, anti-inflammatory agents for frontal fibrosing alopecia, and hairstyle modification for traction alopecia.

Treatment for female hair loss at the temples depends entirely on the underlying cause, and there is no universal solution. It is important to have realistic expectations — most treatments aim to slow progression and support regrowth rather than achieve complete restoration, particularly in scarring conditions.

For non-scarring alopecias, the following options may be considered:

• Minoxidil — the most widely used treatment for female-pattern hair loss. In the UK, the licensed formulations for women are the 2% topical solution (applied twice daily) and the 5% topical foam (applied once daily); the 5% solution is not licensed for use in women. Minoxidil works by prolonging the anagen (growth) phase of the hair cycle and increasing follicular blood supply. It must be used consistently and long-term; stopping treatment typically results in renewed shedding. Common side effects include an initial increase in shedding during the first few weeks of use (which usually settles), scalp irritation or contact dermatitis, and unwanted facial hair (hypertrichosis). Minoxidil is not recommended during pregnancy or breastfeeding. If you experience severe scalp irritation, discontinue use and seek advice from your pharmacist or GP. Topical minoxidil products are generally purchased over the counter rather than prescribed on the NHS.

• Hormonal therapies — in women with androgen-related hair loss, treatments such as spironolactone or co-cyprindiol may be prescribed off-label by a specialist. Spironolactone requires baseline and periodic monitoring of kidney function and potassium levels; reliable contraception is essential during treatment, as it carries a teratogenic risk. Co-cyprindiol carries an increased risk of venous thromboembolism (VTE) and is indicated for severe acne or hirsutism when other treatments have failed; its use for hair loss alone is off-label. Both should only be initiated and supervised by a specialist.

• Nutritional supplementation — correcting confirmed deficiencies in iron, vitamin D, or zinc can support hair regrowth, though supplementation alone is unlikely to reverse significant loss and should be guided by blood test results.

For frontal fibrosing alopecia, treatment typically involves anti-inflammatory and immunomodulatory agents, including topical or intralesional corticosteroids, hydroxychloroquine, or tetracycline antibiotics. These aim to suppress the inflammatory process and halt progression rather than restore lost hair. Hydroxychloroquine carries a risk of retinal toxicity with long-term use; patients should be referred for baseline and regular ophthalmological screening in line with Royal College of Ophthalmologists guidance. Many FFA treatments are available through NHS dermatology services, though access may vary by local Integrated Care Board (ICB) and formulary.

For traction alopecia, the primary intervention is removing the source of tension — changing hairstyling practices — ideally before permanent follicle damage has occurred. Topical minoxidil may support regrowth in early cases.

If you experience suspected side effects from any medicine used for hair loss, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

Managing Temple Hair Loss and Supporting Regrowth

Avoiding tension hairstyles, maintaining a protein- and iron-rich diet, and addressing confirmed nutritional deficiencies support scalp health alongside medical treatment for temple hair loss.

Alongside medical treatment, a number of practical and lifestyle measures can support scalp health and optimise the conditions for hair regrowth. These are not substitutes for addressing the underlying cause, but they form a valuable part of a holistic management approach.

Scalp and hair care:

• Avoid hairstyles that place tension on the temples — opt for loose styles and avoid tight elastics or clips at the hairline

• Use gentle, sulphate-free shampoos and avoid excessive heat styling, which can weaken hair shafts

• Handle hair carefully when wet, as this is when it is most vulnerable to breakage

• Scalp massage may modestly improve blood circulation to follicles, though evidence for significant regrowth benefit remains limited

Nutritional support: Ensure a balanced diet rich in protein, iron, and micronutrients. Foods such as leafy greens, eggs, legumes, nuts, and oily fish support overall hair health. If blood tests have confirmed a deficiency, supplementation under medical guidance is appropriate.

Emotional wellbeing: Hair loss can have a profound impact on self-esteem and mental health. It is entirely valid to seek psychological support alongside medical treatment. Organisations such as Alopecia UK offer peer support, information, and community resources specifically for people experiencing hair loss in the UK.

Cosmetic options such as scalp micropigmentation, hair fibres, or specialist wigs and hairpieces can provide confidence whilst treatment takes effect. NHS wig provision is available for certain diagnoses, though eligibility criteria vary by local trust and ICB policy — your GP or dermatologist can advise on whether you qualify.

Regular follow-up with your GP or specialist is important to monitor progress, adjust treatment as needed, and ensure any evolving underlying conditions are appropriately managed.

Frequently Asked Questions